INTRODUCTION
Hyperpolarized (HP) carbon-13 MR imaging allows for real-time non-invasive measurement of metabolism. Using HP [2-13C]pyruvate as a molecular probe enables the measurement of both aerobic glycolysis ([2-13C]lactate) and oxidative metabolism (such as [5-13C]glutamate and [5-13C]glutamine). This study presents the initial patient experience of acquiring HP [2-13C]pyruvate MR spectroscopic data.
METHODS
Two patients who presented with IDH-mutant gliomas (43 year-old male, grade II astrocytoma, RT/TMZ; 33 year-old female, grade III oligodendroglioma, no RT/TMZ) considered radiologically stable post resection were imaged using a 2D chemical shift imaging (CSI) sequence (15.6–18.8cm3 spatial resolution, 20s acquisition), following injection of 0.43mL/kg of 250mM HP [2-13C]pyruvate. HP [2-13C]pyruvate, [5-13C]glutamate, [5-13C]glutamine, and [2-13C]lactate resonances were quantified within a lesion voxel and contralateral normal-appearing voxel. The proton images were aligned to HP data enabled quantification of apparent diffusion coefficients (ADC), perfusion peak height (PH), and MR spectroscopy choline-to-N-acetyl-aspartate indices (CNI). ADC (nADC) and PH (nPH) values were normalized by the median value in normal-appearing white matter.
RESULTS
Proton exams revealed no Gd-enhancement lesions. For the T2-hyperintense lesion (T2L), volumeT2L=18.4/4.2cc (Patient#1/Patient#2); median ADCT2L =1.86/1.64; max CNIT2L=3.2/6.5; 90th percentile nPHT2L =1.09/2.11. HP data displayed maximum signal-to-noise ratios (SNR) for [2-13C]pyruvate, [5-13C]glutamate, [5-13C]glutamine, and [2-13C]lactate of 1360, 44, 27, and 400, respectively. The HP CSI data contained 15.9/13.7 %T2L; 15.1/4.1 %NAWM; 15.7/22.0 %GM (Patient#1/Patient#2) in selected lesion voxels, while contralateral voxels had %NAWM:%GM of Lesions demonstrated a reduced HP glutamate/pyruvate ratio [#1: 0.0089/0.0102 (lesion/normal voxel); #2: 0.0170/0.0269] and an elevated HP glutamate-to-glutamine ratio in both patients [#1: 0.81/0.66; #2: 0.84/0.66].
DISCUSSION
This first patient experience with HP [2-13C]pyruvate showed adequate SNR for quantifying HP [2-13C]pyruvate, [5-13C]glutamate, [5-13C]glutamine, and [2-13C]lactate resonances. Future studies will optimize imaging protocols and expand the patient cohort to evaluate aberrant metabolism related to IDH-mutant tumor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.